Artificial 🤖 intelligence was NOT the most funded VC category in Q1.

Which one gained 7% extra then?

🏥 Healthcare and biotech startups raised $15.7 billion, or 24% of all VC global funding in Q1.

I’ve invested in 2 companies (one in each category).

@company_crunchbase released their quarterly data with A.I. closing $11.4 billion (17%) as the second largest market segment.

Some of the largest rounds in the space were Moonshot, Figure, and MiniMax.

🧑‍🏫 Key takeaways:

1. We’ll see significant investments in the space for another year or two. But as the market matures, diversification is bound to happen.

2. Healthtech took the lead – and I’m truly happy for that. One of my SeedBlink investments was 💚 @company_inheartmedical and saving human lives ranks higher than optimizing efficiency (though robots can fix us faster).

3. As the key leaders are already well-funded and backed by titans, investors wait to see what directions will be covered from the top and who remains the lead.

4. Funding volumes stay flat in Q1. That’s expected with oversubscribed startups underdelivering and valuations resetting today.

5. Some investment capital will relocate to profitable asset classes yielding dividends. I see more PE models funding cashflow positive companies now. DoNotPay (a robo-lawyer startup) just paid dividends – a precedent in Silicon Valley.

2023 and 2024 have led to notable shifts as the pandemic balloon is coming to the new normal.

Q2 started strong here – expecting several other key milestones in the next few months. What market trends do you foresee before July? ✍️